2 Matching Annotations
  1. Aug 2022
  2. www.nature.com www.nature.com
    Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination
    1
    1. jackiekrauss 29 Aug 2022

      Pozzetto, B., Legros, V., Djebali, S., Barateau, V., Guibert, N., Villard, M., Peyrot, L., Allatif, O., Fassier, J.-B., Massardier-Pilonchéry, A., Brengel-Pesce, K., Yaugel-Novoa, M., Denolly, S., Boson, B., Bourlet, T., Bal, A., Valette, M., Andrieu, T., Lina, B., … Trouillet-Assant, S. (2021). Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination. Nature, 1–9. https://doi.org/10.1038/s41586-021-04120-y

      is:preprint lang:en immunogenicity efficacy Oxford-AstraZeneca vaccine COVID-19 Pfizer-BioNTech booster protection observational study longitudinal immune compromised individual
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41586-021-04120-y
  3. www.ft.com www.ft.com
    Covid has revealed the need for genomic sequencing around the world
    1
    1. jackiekrauss 29 Aug 2022

      Varmus, H. (2021, August 31). Covid has revealed the need for genomic sequencing around the world. Financial Times. https://www.ft.com/content/342fd3c3-5a22-49a0-9cef-135f2ccd8700

      is:news lang:en COVID-19 Delta variant dangerous variant vaccine prior infection mutation genome immune-compromised individual variant of concern genome sequencing clinical finding
    Visit annotations in context

    Tags

    Annotators

    URL

    ft.com/content/342fd3c3-5a22-49a0-9cef-135f2ccd8700